NCT07263438
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07263438
Title Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial (Phenix)
Acronym Phenix
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Hospitalier Universitaire Vaudois
Indications
Therapies
Age Groups: adult | senior
Covered Countries CHE

Facility Status City State Zip Country Details
Universitätsspital Basel NOT_YET_RECRUITING Basel Basel 4031 Switzerland Details
Kantonsspital Aarau NOT_YET_RECRUITING Aarau Canton of Aargau 5001 Switzerland Details
Bern Inselspital NOT_YET_RECRUITING Bern Canton of Bern 3010 Switzerland Details
Luzerner Kantonsspital NOT_YET_RECRUITING Lucerne Canton of Lucerne 6000 Switzerland Details
Centre Hospitalier Universitaire Vaudois RECRUITING Lausanne Canton of Vaud 1011 Switzerland Details
Universitätsspital Zürich NOT_YET_RECRUITING Zurich Canton of Zurich 8091 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field